JUL 13, 2020 9:35 AM PDT

Russia Completes First Human Trial for COVID-19 Vaccine

WRITTEN BY: Annie Lennon

The Sechenov University Center for Clinical Research in Moscow, Russia, has completed its first round of clinical trials for a COVID-19 vaccine candidate. This makes it the first COVID-19 vaccine in the world to have completed human trials. 

In June, Russia approved two clinical for different formulations of a COVID-19 vaccine candidate. One was an intramuscular solution to be tested at the Burdenko Military Hospital. The other was a powdered form to be tested in Sechenov University. The approvals came after trials investigating the vaccines’ toxicity, safety, immunogenicity, and effectiveness in animal models.

Rather than seeing whether the vaccine may effectively prevent COVID-19, Alexander Lukashev, Director of the Institute of Medical Parasitology, Tropical, and Vector-borne Diseases at Sechenov University, said that the objective of this study was to establish the safety of the vaccine for humans. And according to their results, they believe that it is safe. 

The vaccine used by the researchers is a recombinant adenovirus vaccine. This means that, instead of injecting people with weakened or inactive forms of the coronavirus, they used synthetic agents that mimic their properties to induce an immuno-response capable of wiping out the real virus. 

During the study, the participants were kept in isolation with limited contact to the outside world from before tests started to ensure they were not already infected. The first round of testing commenced on June 18th on 18 participants, while the second round happened on 20 volunteers on June 23rd. 

After being given the vaccine, they were to remain in quarantine in the hospital for 28 days. Once released later this month, the volunteers will be further monitored to evaluate their immunity. 

Although promising results, no information on when the vaccine will reach commercialization has been released. More data is also still needed on how effective the vaccine is at preventing infection by the virus. 

 

Sources: LentaRussia TodayForbes

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 10, 2020
Cannabis Sciences
Cannabis Temporarily Relieves PTSD Symptoms
JUN 10, 2020
Cannabis Temporarily Relieves PTSD Symptoms
PTSD (Post Traumatic Stress Disorder) is a mental disorder characterized by flashbacks, nightmares, and severe anxiety f ...
JUN 13, 2020
Cannabis Sciences
CBD Kills Brain Cancer Cells in Petri Dish
JUN 13, 2020
CBD Kills Brain Cancer Cells in Petri Dish
Cannabis products are not only popular for their psychoactive effects. An increasing number of companies and researchers ...
JUL 20, 2020
Cancer
Fighting Cancer with Black Pepper
JUL 20, 2020
Fighting Cancer with Black Pepper
In the never-ending search for the next treatment or cure, many researchers turn towards nature. The study of black pepp ...
JUL 26, 2020
Drug Discovery & Development
AI Creates Proteins that Rival Those in Nature
JUL 26, 2020
AI Creates Proteins that Rival Those in Nature
Proteins are crucial for the function of cells in living organisms. Now, researchers have developed a machine leaning-le ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
JUL 29, 2020
Health & Medicine
New Study to Put Medical Cannabis to a Proper Test
JUL 29, 2020
New Study to Put Medical Cannabis to a Proper Test
Real world use of medical cannabis is going to be put to the test in a first-of-its-kind study that should add a lo ...
Loading Comments...